Comunicação social | HIPRA

who we are

Comunicação social

2022-03-16 08:45

GoodGut and Vall d'Hebron Barcelona Hospital are studying the implementation of the first non-invasive diagnostic test to detect Irritable Bowel Syndrome

Humana

2022-03-11 10:00

AEMPS authorizes Phase IIb second clinical trial of the HIPRA’s vaccine against Covid-19

Humana

2022-02-01 15:33

AEMPS authorizes phase III clinical trial of the HIPRA’s vaccine against Covid-19

Humana

2022-01-20 15:55

The European RBDCOV project will study HIPRA’s Covid-19 vaccine in children, adolescents and immunocompromised patients

Humana

2022-01-13 15:50

AEMPS authorizes Phase IIb clinical trial of HIPRA Covid-19 vaccine

Humana

2021-12-20 09:15

HIPRA’s Covid-19 vaccine shows an effective immunological response with no adverse effects in preclinical trials

Humana